
Agenus Inc
AGENNASDAQ NMS - GLOBAL MARKETKey Statistics
Open
$3.41
Day High
$3.50
Day Low
$3.30
Prev. Close
$3.40
VolumeShares traded today.
597.23K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$145.75M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
2.11
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$7.34
52W LowLowest price over the past 52 weeks.
$2.71
50D MAAverage closing price over the last 50 trading days.
$3.76
200D MAAverage closing price over the last 200 trading days.
$3.82
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
+10.8%1M
-8.9%6M
-20.1%YTD
+8.4%1Y
+2.0%About
Agenus Inc. is a Lexington, Massachusetts-based biotechnology company focused on immunotherapy including immuno-oncology, a field that uses the immune system to control or cure cancer. The company is developing checkpoint modulators (CPMs), patient-specific anti-cancer vaccines, and adjuvants designed for use with various vaccines. CPM development is a particularly fast-moving field, since early products have produced unprecedented clinical benefits for patients.
agenusbio.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade AGEN
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.